Wed Sep 25 10:00:00 UTC 2024: ## Premier Graphene’s Graphene-Enhanced Concrete Receives Independent Validation from Global Construction Giant
**EL CENTRO, Calif., Sept. 25, 2024** – Premier Graphene Inc. (OTC: BIEI) announced today that its proprietary graphene-enhanced concrete has been independently validated by a leading global construction materials company. The company’s research and development team confirmed Premier’s initial findings, which indicated a significant 32% improvement in tensile strength compared to traditional concrete.
The validation came during a Zoom meeting between Premier’s President, Pedro Mendez, and the global company’s R&D team. The independent tests mirrored results reported by Premier in August 2024, reinforcing the potential of graphene-enhanced concrete.
Premier is now awaiting a larger-scale test order and anticipates securing initial orders and long-term supply agreements if the positive results are confirmed through further independent testing.
“We are thrilled with the positive feedback we’ve received, and we look forward to seeing the results of the further concrete testing which is expected to be confirmed and lead to orders,” said Mendez. “This could mark a significant milestone for Premier Graphene and our commitment to advancing construction technologies.”
Beyond concrete, the global construction giant expressed enthusiasm about the performance of Premier Graphene’s and HGI’s concrete additive mix in mortar applications. The additive has shown the potential to significantly improve the strength and longevity of construction materials.
These innovative formulations also hold the key to reducing greenhouse gas emissions in cement production, further underscoring their environmental benefits.
Premier Graphene has a unique approach to graphene production, utilizing industrial hemp to create a high-quality, low-cost material. The company is focused on developing graphene-enhanced products for various markets, including construction, lubrication, and epoxies.
The company is undergoing a corporate name change from Premier Biomedical Inc. to Premier Graphene Inc., and is traded on the OTC Market.